Constellation Brands, Inc.（STZ） · Beverages

Constellation Brands Long-Term Value Research Report

May 29, 2026·~20 min read

Quick ReadPlain-language overview · read this first

Constellation Brands nominally runs beer, wine, and spirits together, but its profit rests almost entirely on beer—it holds the exclusive, perpetual rights to import and sell brands such as Corona and Modelo in the U.S. market, essentially a franchise selling high-end Mexican imported beer to U.S. consumers. FY2026 Beer operating income was $3.161 billion, while Wine and Spirits was only $10.5 million. The report gives a Watch rating: the beer moat is stable, but the entire enterprise is not equally outstanding. The sticking point is the mismatch between price and quality. At a latest share price of about $142.13, the headline P/E of 23.9x is distorted by FY2025's large impairments; on comparable EPS of $11.82 it is only about 12x; cumulative free cash flow over five years is about $8.6 billion, far above cumulative net income of about $3.2 billion, so the core cash generation is not bad—but this is not a business that requires no further investment. The valuation is no longer expensive, yet the margin of safety is still too thin. The biggest uncertainty is whether the weakening of core beer demand is short-term or structural—depletions have turned negative over the last few quarters; next is whether the wine restructuring can avoid repeated impairments, and the capital-allocation discipline of the CEO who took over in April 2026. The conclusion is an insufficient margin of safety: the ideal buy price is $120–135, and only a return to that range gets closer to a Cautious Buy.

Lead
The leading high-end imported-beer franchise in the U.S., anchored by the Corona/Modelo moat. The moat remains strong, but beer depletions have turned negative and the margin of safety is insufficient. Rating Watch: an ideal buy price of $120–135, still below where the stock trades today.

Full report

Prices in the article are as of publication; see the valuation band above for the live price.

Annotation convention: Fact refers to company disclosures, SEC filings, official investor-relations materials, or authoritative market data; Assumption refers to valuation premises; Inference refers to calculations or logical extensions built on facts; Opinion refers to my investment conclusions. This report is written, as far as possible, from the standpoint of "buying a business for the long term" rather than trading short-term price action.

Conclusion First

Investment rating: Watch.

Core judgment: Constellation Brands is a broadly easy-to-understand business, and its true economic engine is very clear: at heart it is a consumer-products company built around high-end imported beer in the U.S., supplemented by a wine and spirits business that is being steadily shrunk and restructured. The company has clear brand, distribution, and scale advantages; in particular, its long-term operating rights and distribution system for Corona and Modelo in the U.S. do constitute a fairly strong moat. But that moat is concentrated mainly in beer, not spread evenly across the whole enterprise. Management's execution in the core beer business is generally reliable, yet its past record in non-core capital allocation has been imperfect, especially the large impairments in the wine business, which show that its ability to "buy assets, integrate them, and keep creating per-share value" cannot earn an unconditionally high mark. On a basis near the U.S. market close of May 28, 2026, STZ trades at about $142.13, with a market cap of roughly $24.82 billion; the headline P/E is about 23.9x, but this TTM basis is distorted by FY2025's large impairments. If instead you look at FY2026 reported EPS of $9.61 or comparable EPS of $11.82, the current price is about 14.8x and 12.0x. This is not an outrageously high price, but for a "balanced, slightly conservative" long-term investor the margin of safety is still not thick enough.

Does the current price offer a margin of safety: Not obviously. I think it is already below my neutral valuation, but not far from my conservative valuation; if what you demand is the classic "Buffett-style" thick margin of safety, the stock right now is more of a "worth researching, worth watching, worth small phased positions" name than a price at which you "should clearly overweight" it.

Better-suited investor type: Better for long-term value investors who can look out more than 10 years and are willing to treat this as a "U.S. high-end imported-beer asset" rather than an "alcohol grab-bag"; less suitable for ordinary investors who want high-certainty, high growth, or who cannot tolerate the volatility of a single consumer-goods category.

Biggest uncertainties: First, whether core beer consumption is merely being suppressed by short-term socioeconomic headwinds, or whether a more durable structural slowdown has already set in. Second, whether wine and spirits, once restructured, can truly return to the promised path of "higher growth, higher margins." Third, whether Nicholas Fink, who took over in April 2026, can extend the core beer moat without committing major capital-allocation mistakes.

Understanding the Business

How this company makes money is not, in fact, complicated. As a matter of Fact, Constellation Brands is an important producer and marketer of beer, wine, and spirits in the U.S. market, but today its profit center is heavily concentrated in beer. In investor materials and public disclosures the company repeatedly emphasizes that its high-end imported-beer portfolio is anchored by Corona Extra, Modelo Especial, Modelo Cheladas, Pacifico, and Victoria; more importantly, the company holds the exclusive, perpetual rights to import, market, and sell the Corona and Modelo brands in the U.S. market. This means what you are buying is not an abstract "alcohol company," but something more like a commercial franchise that can keep selling high-end Mexican imported beer to U.S. consumers.

Who are the customers? On the surface the customers are distributors, retailers, and on-premise channels, but the true economic source is the U.S. end consumer, especially the segment with a persistent preference for high-end imported beer. In its 2025 proxy the company disclosed that its Beer business achieved its 15th consecutive year of volume growth and continued to hold the No. 1 position as a U.S. high-end beer supplier. By Inference, this suggests its demand base is not built purely on promotions, but rests on fairly strong brand preference and channel availability.

How it charges and revenue stability are also easy to understand: essentially it sells alcohol, and revenue moves with shipment volume, destocking cadence, product mix, and price increases together. It is not "subscription revenue" like SaaS, but premium beer brands in a mature consumer market have a quasi-repeat-purchase character, so predictability is higher than for most discretionary consumer goods. The problem is that over the last few quarters demand has come under pressure from strained spending by U.S. Hispanic consumers, immigration policy, and employment and cost-of-living factors, and both beer depletions and shipments have shown strain. In FY2026 Q3, the company disclosed that Beer net sales fell 1% year over year, shipment volume fell 2.2%, and depletions were -3.0%; for the first nine months of FY2026, Beer net sales fell 4% year over year and depletions were -2.7%. Reuters' reporting on management's remarks also indicates that spending pressure on the core Hispanic customer base is an important current variable.

On cost structure, in FY2026 the company delivered net sales of $9.139 billion, gross profit of $4.712 billion, and operating income of $2.721 billion; in the same year net interest expense was $353 million. This shows it is a consumer business with decent gross margins but not fully asset-light—beer in particular still requires ongoing investment in capacity, packaging, logistics, and marketing. In its FY2027 guidance management laid out operating cash flow of $2.4–2.5 billion and capex of about $800 million, which also indirectly shows this is not a "barely needs any more capital" business.

On dependencies, this company is extremely sensitive to a handful of "core facts": it depends heavily on a durable U.S. preference for imported beers such as Corona/Modelo, on smooth Mexican production and cross-border supply chains, on the U.S. three-tier distribution system, and on management not making further large misallocations in non-core areas. FY2026 Wine and Spirits operating income was just $10.5 million, while Beer operating income reached $3.161 billion, which shows the enterprise is now almost equal to "the beer business plus a still-recovering secondary business." From a long-term owner's angle, this actually makes the enterprise easier to understand: what you truly own is the beer franchise.

If the stock market shut for 5 years, I would be willing to hold this business, but with conditions: the entry price cannot be too much of a stretch, and you must accept that what you are buying is first and foremost a "U.S. high-end imported-beer company," not an all-around, flawless high-quality alcohol holding company. Business comprehensibility score: 4.5/5.

Industry Landscape and Moat

The alcohol industry as a whole is not a high-growth industry; it is closer to competition within a high-quality niche of a mature industry. At the aggregate level, alcoholic beverages are shaped over the long run by demographics, health awareness, consumer preferences, price-band migration, and regulation—it is by no means an industry that "grows fast while lying down." But niche players with strong brands, strong distribution, and strong cultural resonance can still create value through mix upgrades and price increases. What makes Constellation special is that it is not betting on the entire alcohol market, but on the more resilient pocket of U.S. high-end imported beer. In its 2025 proxy the company disclosed that its Beer business continued to hold the No. 1 high-end beer supplier position and captured industry-leading share gains in the U.S. channels tracked by Circana.

But the industry also faces obvious real pressures. The latest round of pressure does not come from "someone inventing a better beer," but from softening consumer spending, channel inventory rebalancing, overall weakness in the wine category, and external disruptions from policy and tariffs. In both FY2026 Q3 and the first nine months, the company explicitly noted that the Beer business was suppressed by socioeconomic factors; over the same period Wine and Spirits was affected by post-divestiture base effects, strategic price increases, and retaliatory tariffs in certain international markets. As a matter of Opinion, this means it is "a good company in a good industry," but not "a good industry with no wind or waves." I score industry attractiveness at 3.5/5.

The moat needs to be taken apart, rather than settled with a single "the brand is strong." The matrix below is closer to a long-term owner's perspective.

Moat factor	Assessment	Basis
Brand advantage	Strong	Corona, Modelo, Pacifico, and others hold long-standing positions in the U.S. high-end imported-beer market; the company emphasizes it is the No. 1 U.S. high-end beer supplier.
Cost advantage	Moderate	Beer scale, procurement, logistics, and Mexican capacity give a unit-cost advantage, but not the extreme low-cost model of a Costco.
Scale advantage	Strong	A large-volume brand portfolio, nationwide distribution capability, and marketing resources form a scale barrier.
Network effect	Weak/none	Not a platform business; network effects are essentially absent.
Switching cost	Weak	The cost of switching brands is low for consumers, but brand preference and occasion-based mindshare create a "soft stickiness."
Distribution advantage	Strong	Under the U.S. three-tier distribution system, strong brand plus deep distribution is the core barrier.
License/regulatory barrier	Moderately strong	Alcohol regulation, cross-border supply chains, and brand licensing form entry barriers; the exclusive, perpetual license is especially important.
Data advantage	Weak	Data is not a core competitive strength.
Culture/operating capability	Moderate	Strong execution in the beer business, but the enterprise level is dragged down by the wine restructuring.
Capital-allocation capability	Moderately weak	Reinvestment in the core business is effective, but the history of non-core allocation into wine/cannabis is not pretty.

The "strong/moderate/weak" ratings above are judged mainly on the company's exclusive U.S. brand licenses, its brand share and channel position, and the vast difference in profitability between Beer and Wine and Spirits in the financial results.

For an overall assessment of the moat, I would put it this way: the Beer moat is stable, while the enterprise-wide moat has narrowed slightly. The reason it is not "widening" is that two recent facts cannot be ignored: first, Beer depletions have been negative for several quarters, showing that even the strongest brand is affected by consumer purchasing power and channel destocking; second, the large Wine and Spirits impairments prove the non-core parts of the enterprise are not stable. In other words, the beer moat is still there, but the "sum of quality" at the enterprise level is not as high as the market imagined a few years ago. Moat strength score: 4/5.

On performance in inflationary and recessionary environments, the company's history shows it has some pricing power, but not unlimited pricing power. A meaningful part of FY2025 Beer net-sales growth came from pricing, and when Beer net sales fell in the first nine months of FY2026, the company also noted a $116.5 million positive contribution from pricing, only offset by volume and mix. This shows it is not without pricing power, but that pricing power is constrained by demand elasticity. In a recession it would most likely still be profitable; at a minimum, even under demand pressure in FY2026 the company still posted $2.721 billion of operating income and $2.669 billion of operating cash flow.

Management and Capital Allocation

Let me state the conclusion first: management is not "untrustworthy," but it is definitely not in the tier that "unconditionally deserves all your capital." Management and capital-allocation score: 3/5.

On the positive side, management's execution on the core beer franchise is broadly acceptable. It invests in brand and distribution while continuing to buy back stock and maintain a cash dividend; in FY2026 the company returned more than $1.6 billion to shareholders, of which buybacks exceeded $900 million; in 2025 the board also newly approved a $4 billion repurchase authorization expiring in 2028. FY2026 operating cash flow was $2.669 billion, and the debt balance fell from $12.461 billion in FY2023 to $10.569 billion in FY2026, showing that at least along the "earn, repay, dividend, buyback" main line, cash has not gone out of control.

But the negative side is equally clear. The most telling counter-evidence comes from the wine business. In FY2025, because Wine and Spirits kept weakening, the company first took a $2.25 billion goodwill impairment in the second quarter, added another $490.7 million by year-end, and took a further $57 million impairment on certain trademarks; at the same time, around the 2025 Wine Divestitures transaction it recognized another $478 million of held-for-sale impairment. As a matter of Opinion, this is not evidence of accounting fraud, but it clearly shows that past judgments about the value of wine assets were too optimistic, and capital allocation lost significant marks at least in this area.

Now consider buyback quality. In February 2026 the company repurchased 646,824 shares at an average price of $154.60; after April 17, 2026 it continued buying back at an average of $153.86. By comparison, STZ's market price on May 28, 2026 was about $142.13. This shows the company is still buying back, but these buybacks did not clearly occur in a deeply undervalued zone; at least with hindsight they were not especially "shrewd." This is not a fatal problem, but it means buybacks look more like a routine capital-return tool than a highly counter-cyclical, well-timed act of capital allocation.

On governance and shareholder structure, the picture is mixed. As a matter of Fact, as of the 2025 proxy record the Sands Family Group held about 12.0% of the Class A stock and retained certain director-nomination rights; Berkshire Hathaway also held about 6.8%. This means the company does have relatively long-term-oriented large shareholders behind it. At the same time, under the latest verifiable proxy basis, the direct holdings of professional managers such as William Newlands, Garth Hankinson, and Nicholas Fink are not large, indicating that management's personal economic alignment is not especially strong. Add to that the fact that in April 2026 the CEO role was handed over to Nicholas Fink, so management is in a transition period, which itself adds execution uncertainty. It should be noted that, as of 2026-05-29, the 2026 proxy has not yet been publicly disclosed, so for the ownership and governance portion I use the 2025 proxy as the latest verifiable basis.

If I had to sum up capital allocation in one sentence, I would write it this way: reinvestment in the core business is passable, judgment on non-core assets is blemished, buybacks are continuous but not especially clever, and debt management is broadly rational.

Financial Quality and Owner Earnings

Look at financial quality first, not P/E first. Over the past five years the financials have one very important feature: cash flow looks markedly better than GAAP net income. The reason is no mystery—two kinds of non-cash, non-core items repeatedly distort the statements: one comes from unconsolidated investments and Canopy-related items; the other from impairments of wine and related assets. From FY2022 to FY2026, net income attributable to shareholders was roughly -$40 million, -$71 million, $1.727 billion, -$81 million, and $1.687 billion, highly volatile; but operating cash flow over the same period was roughly $2.705 billion, $2.757 billion, $2.780 billion, $3.152 billion, and $2.669 billion, remarkably stable by contrast.

The table below organizes the key metrics on a consistent basis for FY2022–FY2026. Free cash flow in the table is computed as "operating cash flow minus capex for property and equipment," and is an Inference value.

Fiscal Year	Revenue	Operating Income	Net Income to Shareholders	Operating Cash Flow	Capex	Free Cash Flow	Total Debt	Cash	Shareholders' Equity
FY2022	88.21	23.32	-0.40	27.05	10.27	16.79	104.17	1.99	120.48
FY2023	94.53	28.43	-0.71	27.57	10.35	17.22	124.61	1.34	87.34
FY2024	99.62	31.70	17.27	27.80	12.69	15.11	118.79	1.52	100.65
FY2025	102.09	3.55	-0.81	31.52	12.14	19.38	114.98	0.68	71.35
FY2026	91.39	27.21	16.87	26.69	8.75	17.94	105.69	1.02	83.87

Unit: US$100 million; total debt is the total debt outstanding disclosed for the year, and shareholders' equity is total stockholders' equity. The table above is compiled from the company's FY2022–FY2026 10-Ks/annual reports.

Looking at the trend, revenue has not risen in a straight line. From FY2022 to FY2025 enterprise revenue grew from $8.821 billion to $10.209 billion, but in FY2026 it fell back to $9.139 billion due to the Wine & Spirits divestiture and other factors. If you strip out the wine-restructuring noise, the beer business's value is more stable, while the enterprise's overall revenue is distorted by portfolio changes. More meaningful is the cash: cumulative operating cash flow over the five years FY2022–FY2026 was about $14.06 billion, and cumulative free cash flow about $8.64 billion, far above cumulative net income to shareholders of about $3.22 billion over the same period. As a matter of Opinion, this shows profit quality at the core operating level is not bad at all; rather, it is the accounting items that distort "surface earnings."

On margins, if you use the GAAP operating margin the company is very volatile; in FY2025, due to impairments and asset disposals, the operating margin briefly dropped to about 3.5%. But if you look at comparable operating income, the company's operating foundation is actually clearer: FY2024 comparable operating income was $3.246 billion, FY2025 was $3.475 billion, and FY2026 was $2.943 billion. This shows the true operating capability has not collapsed as violently as the statements suggest; it is just that FY2026's beer demand pressure and mix change are turning from "accounting volatility" into "operating reality."

The balance sheet is not fragile, but it is by no means comfortable. FY2026 total debt was $10.569 billion and cash was $102.4 million, an Inference net debt of about $10.466 billion. Estimating from FY2026 operating income of $2.721 billion and D&A of about $420 million, EBITDA is about $3.14 billion, net debt/EBITDA is about 3.1x, and interest coverage is about 7.7x. This is a "manageable but must-be-respected" level of leverage. It is not debt that will crush the enterprise, but it is enough to require more caution when judging whether demand is recovering.

Changes in working capital are not a disaster for the company. From FY2024 to FY2026, inventory fell from $2.078 billion to $1.437 billion and then $1.434 billion; accounts receivable fell from $833 million to $737 million and $658 million; accounts payable fell from $1.107 billion to $940 million and then edged back up to $960 million. This shows that during the wine restructuring and demand slowdown, overall working capital did not continuously consume cash; on the contrary, it was released to some degree.

On financial manipulation and aggressive accounting, I see no direct evidence that the company engages in fraud or systematic earnings manipulation; but I remain cautious, because a string of large impairments at least shows management's past judgments on asset value, long-term growth, and brand portfolio were off. In other words, the risk looks more like "strategy and capital allocation being too optimistic" than "cash flow that does not exist." Both matter to long-term investors, just in different ways.

Next, look at Owner Earnings. For STZ, I prefer to start from operating cash flow rather than adding to and subtracting from net income. FY2026 operating cash flow was $2.669 billion, and total capex was $875 million. If you treat all capex as maintenance capex, equity free cash flow is about $1.794 billion, the most conservative basis. If you consider that a large share of the company's recent capex is tied to Mexican beer capacity expansion, and that the Veracruz Brewery's initial startup is still expected in late FY2026 or early FY2027, then treating part of the capex above depreciation as growth capex is reasonable. Based on the conservative but not extreme Assumption that "maintenance capex = D&A of $420 million + 25% of the portion above depreciation," FY2026 maintenance capex is about $530 million, corresponding to owner earnings of about $2.14 billion. That equates to roughly 11.5–11.6x owner earnings at the current share price.

My conclusion is: STZ's true earning power is clearly higher than its surface net income, and its long-term free cash flow and owner earnings are both substantial; but this is not a business that requires no invested capital, and its true "cash character" is not as pure as that of the very best spirits companies.

Valuation, Margin of Safety, and Opportunity Cost

Look at the price the market is currently offering first, then discuss value.

As of the most recent trading point on May 28, 2026, STZ traded at about $142.13, with a market cap of roughly $24.82 billion. Combined with FY2026 reported figures, the current price corresponds to about 14.8x FY2026 GAAP EPS of $9.61 and about 12.0x FY2026 comparable EPS of $11.82; measured against FY2026 reported free cash flow of $1.794 billion, the equity FCF yield is about 7.2%; and measured against the conservative owner earnings of $2.14 billion above, the owner-earnings yield is about 8.6%. Taken together, these bases show it is not absurdly expensive, but the market is not handing out gifts either.

I split valuation into three layers.

Owner-earnings discounting. What is discounted directly here is the owner earnings "attributable to shareholders, already after interest and tax," so what you get is equity value. My three sets of Assumptions are as follows: Conservative scenario: owner-earnings starting point $1.85 billion, 10-year annual growth of 2%, discount rate 9%, terminal growth 2%; Neutral scenario: starting point $2.05 billion, 10-year annual growth of 4%, discount rate 8.5%, terminal growth 2.5%; Optimistic scenario: starting point $2.2 billion, 10-year annual growth of 5.5%, discount rate 8%, terminal growth 3%. These assumptions build on FY2026 cash flow, FY2027 operating cash flow/capex guidance, and the company's target of more than $200 million in annualized cost savings by 2028.

Under these assumptions, my Inference results are roughly: Conservative intrinsic-value range: $145–160 per share; Fair intrinsic-value range: $180–220 per share; Optimistic intrinsic-value range: $250–300 per share. The current $142.13 shows only a very shallow discount to the conservative range, and a moderate discount to the fair range. For a conservative investor, the most meaningful line is the first, not the third.

Relative valuation. On the surface, STZ's current TTM P/E is about 23.9x, Brown-Forman about 15.1x, and Diageo about 20.1x, so STZ does not look cheap; but STZ's headline P/E is spoiled by the FY2025 large impairments, and on the basis of FY2026 comparable EPS of 11.82 it is closer to 12x. On a cash basis, STZ's current equity FCF yield is about 7%+, whereas in the public market Brown-Forman's FCF yield is about 5%. As a matter of Opinion, what is truly attractive about STZ now is not its GAAP P/E, but that "beneath the distorted accounting earnings, the core beer franchise is still spitting out very strong cash." That said, because accounting bases, ADR structures, and capex cycles differ substantially across companies, cross-company comparisons of P/B, EV/EBITDA, and ROIC are easily distorted, so this is better used for directional judgment than pretended precision.

Asset or liquidation value. For STZ, this method is of limited use. At the end of FY2026, total assets were $21.901 billion, of which goodwill was $5.234 billion and intangible assets $2.533 billion, together a large share; total shareholders' equity was $8.387 billion. By Inference, after stripping out goodwill and intangibles, net tangible book value is very thin, so P/B has almost no explanatory power for this company. When you buy STZ, you are not relying on a "liquidation-value floor," but on the ability of the Corona/Modelo assets to generate cash over the next 10 years. And precisely for that reason, the margin of safety must come from price and cash return, not from asset revaluation.

If you force me to make the "buy, hold, clearly overvalued" price bands more operational, I would draw them this way: Ideal buy price: $120–135. This corresponds to a more respectable discount to conservative value; Acceptable holding price: $135–170. This range is not cheap, but may still give long-term investors a reasonable return; Clearly overvalued price: above $200. In this zone, the margin of safety thins out sharply and becomes increasingly reliant on the optimistic scenario. So the current price is not "un-buyable," but it is more of a "worth tracking continuously, waiting for better odds" situation. For your "balanced, slightly conservative" risk preference, I think the margin of safety is insufficient.

This matters especially when compared with other opportunities. The U.S. 10-year Treasury has recently yielded about 4.45%–4.50%; STZ's current dividend yield is about 2.87%, its reported free-cash-flow yield about 7.2%, and its owner-earnings yield about 8.6%. On static yields, STZ is indeed a few percentage points above the risk-free rate, but those few points must be exchanged for single-brand concentration, leverage, policy, demand, and management-execution risk—the advantage is not large enough to jump in blindly. Meanwhile, SPY trades at about $754.6, and Reuters has also reported the S&P 500 hitting an all-time high; the index is certainly not necessarily cheap, but its diversification advantage is far greater than STZ's. As a matter of Opinion, whether buying STZ is clearly better than buying the index depends on whether you truly believe its imported-beer franchise will stay strong over the next 10 years, not merely on believing that "someone will always drink alcohol." For conservative capital, the bar for that judgment should be higher.

Risks, Checklist, and Final Judgment

The most important risk is not price volatility, but permanent loss of capital. I think the following types of risk must be watched.

The first is competition and demand risk. If Modelo/Corona's brand momentum in the U.S. high-end imported-beer market weakens, or if the spending pressure on the core Hispanic customer base proves structural rather than short-term, then today's valuation basis for the beer franchise will be marked down. The negative depletions of the last few quarters have already reminded us: even the best brand is not immune to volume pressure.

The second is regulatory, tariff, and supply-chain risk. The company's core beer profit depends heavily on the smooth link between Mexican production and U.S. market sales; in FY2026 the company explicitly noted that certain businesses were affected by U.S. tariffs and retaliatory measures. If the cross-border cost structure is disrupted over the long term, then what you buy today is not a "perpetual-license cash cow" but a "policy-repriced licensed asset."

The third is management and capital-allocation risk. The strongest bear thesis is not complicated: what this company is truly excellent at is beer, and the market knows it; and the company has already proven historically that its capital allocation outside beer does not always create value. The large 2025 wine impairment is the most direct evidence. Add to that the fact that the CEO has just changed, and the new management has not yet completed a full operating cycle inside STZ. If large non-core acquisitions, out-of-industry bets, or new impairments occur again, what you should question is "whether management is repeating old mistakes," rather than granting it more time for its story.

The fourth is the combined risk of valuation and leverage. The current price is not especially high, but if you buy without a margin of safety, and growth over the next two years continues to fall short, margins keep declining, and the market again treats STZ as a "low-growth beer stock," then the valuation multiple and earnings could compress together. By Inference, if normalized EPS is left with only $8 and the market gives just 8–10x, the share price could land in the $64–80 range, a decline of 44%–55% from the current price. That is my understanding of the maximum permanent-loss scenario: not bankruptcy, but "good brand + mediocre allocation + growth stall + leverage" jointly pushing the valuation center much lower.

Below is your investment checklist, kept as direct as possible.

Checklist question	Conclusion
Can I understand this business?	Pass
Does it have durable, stable demand?	Pass
Does it have a durable moat?	Pass, but concentrated mainly in beer
Does it have pricing power?	Pass, but limited
Can it generate stable free cash flow?	Pass
Is its return on capital excellent?	Pass, but the enterprise as a whole is less excellent than the beer unit alone
Is management trustworthy?	Uncertain
Is capital allocation rational?	Between fail and uncertain, closer to a weak "uncertain"
Is the balance sheet sound?	Pass, but not comfortable
Is the valuation below intrinsic value?	Pass, but by a limited margin
Is the margin of safety sufficient?	Fail
Does holding it long-term leave me at ease?	Uncertain
Which key facts would make me sell?	Continued deterioration in beer depletions, margins breaking below the central level, worsening leverage, another large capital misallocation
Do I want to buy only because the price has fallen or out of emotion?	I must stay wary of this

The conclusions above are a composite judgment based on the company's financials over the past five years, the latest guidance, changes in demand, the capital-allocation history, and the current market price.

Final rating: Watch.

One-line investment thesis: What is truly valuable about STZ is its U.S. high-end imported-beer franchise, not the entire enterprise being equally outstanding; the current price is no longer expensive, but for slightly conservative long-term value investors the margin of safety is still too thin.

Core bull points:

The core asset is clear, and the exclusive, perpetual operating rights to Corona/Modelo in the U.S. are highly scarce.
The beer business's brand and distribution moat is still strong, with an excellent long-term share position.
Operating cash flow has been durable over the long run, and cumulative free cash flow over the five years FY2022–FY2026 is clearly higher than cumulative net income to shareholders.
On FY2026 comparable EPS and owner earnings, the current price is not expensive.
If the wine restructuring and cost savings come through, there is still room for the enterprise's overall margins to recover.

Core bear points:

Beer depletions have turned negative over the last few quarters; the core demand pressure is real.
The large Wine & Spirits impairments show that past capital allocation contained significant errors.
The enterprise is almost dominated by a single profit source, and its diversification is not as good as it looks on the surface.
Although leverage is manageable, it is not low; if operations turn down, shareholder returns will be constrained by debt first.
The recent average buyback price is above the current market price, showing that capital-return actions continue but are not exactly "buying heavily when cheap."

Key assumptions:

The Beer business recovers to at least low-single-digit volume/revenue growth over the next 2–3 years.
FY2027 operating cash flow can approach the company's stated $2.4–2.5 billion range.
Wine and spirits, once restructured, no longer experience large, repeated impairments.
Management no longer makes value-destroying non-core capital allocations.

Fair buy price: $120–135. The basis is that I need at least a more respectable discount to my conservative value range of $145–160, rather than merely "slightly below fair value."

Target holding period: At least 5–10 years; more precisely, it should be measured by one full consumption cycle and one execution cycle of the new management team.

Expected annualized return:

Conservative scenario: 5%–7%.
Neutral scenario: 8%–11%.
Optimistic scenario: 12%–14%+. This is an Inference based on dividend yield, owner-earnings growth, buybacks, and valuation reversion, not a price forecast.

Maximum loss risk: If the Beer demand slowdown proves structural, and the market views STZ as a low-growth, highly leveraged single-brand company with a history of capital misallocation, there is in theory a 40%–55% medium-to-long-term capital drawdown risk.

Tracking metrics:

Beer depletions and shipments.
Whether Beer operating margin holds near 37%–38%.
Operating cash flow and capex, especially whether FY2027 approaches guidance.
Whether net debt/EBITDA keeps declining.
Wine & Spirits organic growth and operating margin.
Whether large impairments or non-core investments recur.
Buyback execution price and cadence.
The new CEO's strategy and capital-allocation actions after taking office.

Signals that would trigger a reassessment:

Beer depletions stay clearly negative for several consecutive quarters with no visible recovery trend.
Beer operating margin breaks below 35% and cannot recover.
Net leverage rises again and stays above about 3.5x over the long term.
Another larger-than-expected impairment or restructuring occurs.
The new management undertakes a large M&A deal or capital allocation that strays from the core business.

Open questions / limitations: As of 2026-05-29, the 2026 proxy has not yet appeared as a public filing, so management ownership and the latest compensation arrangements can only rely on the 2025 proxy; peer cross-comparisons of P/B, EV/EBITDA, and ROIC are, because of differing accounting bases, ADR structures, and data availability, treated here only as directional judgments, not passed off as a "single-basis precise database."

Final recommendation: This is "the very good part" within a company—the U.S. high-end imported-beer franchise—worth researching for the long term; but the whole company still carries the shadow of the post-restructuring wine business and the creases of management's capital-allocation history. For balanced, slightly conservative 10-year capital, I would not rush to buy heavily just because it "looks cheaper." I would rather put it on the high-priority watch list: if the price returns to $120–135, or the core Beer metrics again prove that demand is recovering, then it would move from "Watch" closer to "Cautious Buy"; at the current price, the more appropriate action is to stay disciplined and allow yourself to miss a small stretch of upside in exchange for a thicker margin of safety.

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.

Mentioned Tickers

BF DEO CGC

Baillie Framework · Ten Questions for Growth Investing

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

How high is its market ceiling? Is it enlarging a slice of an existing pie, or creating an entirely new market?4/10

Conclusion: the ceiling is on the low, mature side—Constellation is essentially grabbing share and doing mix upgrades within an "existing pie that no longer grows fast," rather than creating an entirely new market. This is precisely the first hard constraint that keeps it from fitting Baillie Gifford's "5x in ten years" narrative.

The report is very blunt about the industry's nature: alcohol is "by no means an industry that 'grows fast while lying down,'" and is closer to "competition within a high-quality niche of a mature industry," suppressed over the long run by demographics, health awareness, consumer preferences, and regulation. What makes Constellation special is not betting on the whole alcohol market, but betting on "the more resilient pocket of U.S. high-end imported beer"—that is, eating deeper into the best corner of an existing pie, rather than opening up virgin territory.

The "ceiling" of the ceiling can be calibrated from a few facts. First, the company's profit is already highly concentrated in beer: in FY2026 (ended 2026-02-28) Beer net sales were $8.315 billion and operating income $3.161 billion, while Wine & Spirits full-year operating income was only about $10.5 million on the report's basis—almost all the incremental room hangs on a single high-end beer category. Second, this category is currently contracting rather than expanding: for full-year FY2026, Beer net sales fell 3%, shipment volume fell about 3.8%, and full-year depletions were -2.1%, which the report attributes to spending pressure on the U.S. Hispanic core customer base, immigration policy, and employment and cost of living. A "pie" that is being enlarged does not show consecutive negative volumes.

It is indeed "enlarging its own share within the existing pie"—the report cites the company's account that Beer remains the "No. 1 U.S. high-end beer supplier" and captures industry-leading share gains in the channels tracked by Circana; in FY2026 the company also states it continued to deliver leading beer share gains in Circana's U.S. tracked channels. But this is "grabbing existing volume, grabbing share," not the "creating a market that did not exist before" that Baillie Gifford values most.

From Baillie Gifford's lens: a true LTGG target should have a market ceiling high enough to allow an order-of-magnitude jump in revenue within ten years; STZ's reality is a share champion within a mature beverage category, with its TAM capped by demographics and drinking habits, and mix upgrades and price increases as the main value sources. On this dimension, its "resilience and share" are facts, but "high ceiling, able to create a new market" does not hold—without inflating the growth narrative, this should be honestly marked as a clear shortcoming under this framework.

Jun 10, 2026
Can its revenue at least double over the next five years? Is growth driven mainly by volume, price, or new businesses?2/10

Conclusion: almost impossible. Doubling revenue over the next five years (≈15% annualized) far exceeds this business's physical ceiling—it is not even achieving positive growth right now, and its growth engine is "price" rather than "volume," let alone new businesses. This is STZ's most failing item among Baillie Gifford's ten questions.

First, the starting point and direction. In FY2026 the company's total net sales were $9.139 billion, down 10% year over year (including the Wine divestiture base effect); even the true engine, beer, was net sales -3%, shipment volume -3.8%, depletions -2.1% for the year. A business set to double in five years should be accelerating; STZ is now stabilizing after contraction. Doubling in five years requires about a 15% compound growth rate, for which a high-end beer maker in a mature market has no realistic path.

Next, the driver structure—growth comes from price, not from volume, and even less from new businesses. The report notes that when Beer net sales fell in the first nine months of FY2026, pricing still contributed a positive $116.5 million, only offset by volume and product mix; the company itself also confirms FY2026 "shipment declines of 3.8%, partially offset by favorable pricing net of mix". In other words, the only variable currently moving up is price increases, and the report is explicit that pricing "is constrained by demand elasticity" and is not unlimited. Volume is falling, price has a ceiling, and Wine & Spirits is still contracting and restructuring (FY2026 segment operating income only about $10.5 million); none of the three engines can carry a doubling.

The company's own medium-term guidance also confirms "low speed" rather than "doubling." Management's FY2027 basis is operating cash flow of $2.4–2.5 billion, capex of about $800 million, and comparable EPS of $11.20–11.90—the midpoint of the comparable-EPS range is nearly flat versus FY2026's 11.82, meaning the company's baseline expectation for next year is "flat to slightly up," and EPS still includes a buyback contribution. For a company whose own guidance is near zero growth, talking about doubling revenue in five years is detached from the facts.

The honest conclusion from Baillie Gifford's lens: on this dimension STZ is a cautionary example. It is not a growth stock of "volume and price rising together plus new businesses igniting," but a mature consumer product of "volume under pressure, propped up by price, with the portfolio still contracting." The report even sets its key assumption only at "Beer recovering to at least low-single-digit volume/revenue growth over the next 2–3 years"—even the report's most optimistic internal assumption is only "low single digits," an order of magnitude away from "doubling in five years." Without inflating the narrative: here the answer is simply "no."

Jun 10, 2026
Five years out, what will take over as the next growth engine? Does this "second curve" exist today?3/10

Conclusion: there is no clear "second curve." The "next engine" visible today is not a new growth pole, but "core beer stabilizing + wine restructuring stanching the bleeding + cost savings"—essentially repairing the existing base, not opening up new increments. What Baillie Gifford wants—"does the new engine that will take over in five years already exist today"—for STZ, the answer is essentially no.

First, rule out a few candidates often mistaken for a second curve. First, Wine & Spirits is not a second curve but a drag being shrunk: FY2026 segment operating income on the report's basis was only about $10.5 million, and the company is still advancing wine-asset divestitures; in FY2025 it even took several billion dollars of goodwill impairment on this business (the report records $2.25 billion in the second quarter, another $490.7 million added at year-end, a further $57 million trademark write-down, plus $478 million of held-for-sale impairment on the 2025 Wine Divestitures). A segment with consecutive large impairments that is being sold off is exiting, not taking over. Second, the cannabis (Canopy)-related exposure is listed in the report as a non-cash, non-core item that repeatedly distorts the statements—a lesson from history, not a future engine.

So what does the company's hoped-for "re-acceleration of growth" rely on? The report and company guidance jointly point to three things, but all are "repair + efficiency" rather than "new market": (1) core beer returning to low-single-digit growth after socioeconomic pressure eases (the report's key assumption); (2) Mexican capacity expansion supporting beer supply—the Veracruz Brewery's initial startup is expected in late FY2026 or early FY2027, a matter of capacity rather than a new category; (3) cost savings, with the company setting a target of more than $200 million in annualized cost savings by 2028, which is margin repair, not a revenue second curve. The company's FY2027 operating-margin guidance of 32%–33% is also a steady-state operating basis, reflecting no new growth pole.

Filling in the implied premise in the chain—"does this second curve exist today?": there is no independent, quantifiable new growth curve. At most, what can be seen is the core beer's gradual extension into premiumization and new flavors (Modelo Cheladas, Pacifico, etc.), a natural extension of the main curve that does not constitute a "second S-curve" in the Baillie Gifford sense. For a genuinely new category, new geography, or new business model, the report offers no substantive vehicle.

The honest conclusion from Baillie Gifford's lens: STZ is a "single-curve, relying-on-core-repair" target. Its future is determined by whether the single Corona/Modelo curve can climb again, not by a new engine already incubated to take over in five years. On this dimension, record it honestly as "weak."

Jun 10, 2026
What is its core competitive advantage? Will this moat widen or narrow over the next three to five years?6/10

Conclusion: the core moat (exclusive, perpetual operating rights to U.S. high-end imported beer + brand + distribution scale) is genuinely wide and scarce; but at the "enterprise-wide" level and looking three to five years out, the moat is "stable but slightly narrowing," not widening. The report's judgment is "the Beer moat is stable, while the enterprise-wide moat has narrowed slightly," and I agree—on this dimension STZ's "quality" is very good, but its "upward margin" is not strong.

The moat's sources are solid and concentrated in beer. The hardest piece is the legal/licensing barrier: the company holds exclusive, perpetual rights to import, market, and sell Corona, Modelo, and other brands in the U.S. market, equivalent to a franchise "able to keep selling high-end Mexican imported beer to U.S. consumers." This has translated into very strong profitability—FY2026 Beer operating income of $3.161 billion, against Beer net sales of $8.315 billion, an operating margin of about 38%, direct evidence that "the moat has been converted into profit," not left only in narrative. Layered on top are the brand (No. 1 U.S. high-end beer supplier), the channel depth of nationwide three-tier distribution, and Mexican capacity and procurement scale, together forming multiple barriers. In the report's moat matrix, brand/scale/distribution are judged "strong" and licensing/regulation "moderately strong," which holds up.

But whether it "widens or narrows over the next three to five years" must be judged on the forward margin, and the historical high margins only prove it "was once wide." Two facts weigh down the possibility of "widening": first, even the strongest brand cannot hold off demand and destocking—for full-year FY2026, Beer depletions were -2.1% and shipment volume -3.8%, showing the moat can hold share but not "sustained volume growth"; second, there is real quality erosion at the enterprise level—the consecutive large Wine & Spirits impairments (FY2025 goodwill impairments totaling over $2.7 billion) prove the non-core parts are unstable, pulling the "enterprise-wide moat" narrower.

Switching cost and network effect are naturally weak: the cost for consumers to switch beer brands is low (the report rates it "weak," relying on brand mindshare for soft stickiness), and the business is non-platform with no network effect (rated "weak/none"). This means the moat's sustainability rests mainly on the tripod of "exclusive license + distribution + brand mindshare," rather than a self-reinforcing flywheel—precisely the structural reason it is "stable" but hard to "widen."

The honest conclusion from Baillie Gifford's lens: as a moat, the purity and pricing power of STZ's beer business (about 38% operating margin) are high-quality, far more solid than many "story-type" growth stocks; but Baillie Gifford asks "will it be wider in the future," and the forward margin (volume falling, customer base under pressure, policy/tariff disruption, non-core drag) points to "flat to slightly narrower." Record it honestly: the moat is strong (4/5), but the direction is not expansion.

Jun 10, 2026
If the core business were disrupted, does it have the genes to reinvent itself? How does it treat mistakes and bad news?4/10

Conclusion: the self-reinvention genes are on the weak side, but its "treatment of mistakes" in recent years has been honest. STZ has not demonstrated the ability to rebuild a second curve after being disrupted; instead it has left a record of "repeatedly making mistakes in non-core areas." Yet the way it handles bad news—booking large impairments, shrinking to stanch the bleeding—is to face it rather than cover it up. On this Baillie Gifford supplementary question (the genes to reinvent when the core is disrupted), STZ is "able to admit mistakes, hard to be reborn."

First, the "self-reinvention genes"—weak. This business's value hangs heavily on a single curve: the exclusive perpetual license for Corona/Modelo in the U.S. The report repeatedly emphasizes "what you truly hold is the beer franchise," with FY2026 Beer operating income of $3.161 billion and Wine & Spirits only about $10.5 million, almost "beer plus a secondary business under repair." Its two historical attempts to open new curves—the big push into wine and the cannabis bet through Canopy—both failed: the former brought over $2.7 billion of goodwill impairment in FY2025 and ultimately led to asset divestiture, while the latter became a non-cash, non-core drag that repeatedly distorted the statements on the report's basis. In other words, when the company tried to "reinvent," the result was value destruction rather than renewal. This is exactly the opposite of the "core hit but still able to incubate a new engine" that Baillie Gifford admires.

But "how it treats mistakes and bad news"—here STZ does not do badly, and deserves fair credit. Facing the deterioration of the wine business, management did not delay or whitewash but booked the problem in one go: in FY2025 Q2 it first took a $2.25 billion goodwill impairment, added another $490.7 million at year-end, took $57 million on certain trademarks, and recognized a further $478 million held-for-sale impairment around the 2025 Wine Divestitures, then began divesting and shrinking the front line. The report's characterization is apt: "this is not evidence of accounting fraud, but it clearly shows that past judgments about the value of wine assets were too optimistic"—that is, acknowledging "strategy and capital allocation being too optimistic" rather than "cash flow that does not exist." Publicly booking mistakes and adjusting business boundaries accordingly is a healthy error-correction culture.

Filling in the implied premise in the chain—"the genes to reinvent when the core business is disrupted": this is precisely the biggest soft spot. If one day high-end imported beer is structurally disrupted (health trends, tariffs permanently damaging Mexican cross-border costs, long-term contraction of the Hispanic customer base), STZ lacks a proven "rebuild path"—every past attempt to leave beer in search of new growth was frustrated. So its disruption resilience comes more from "the core being strong enough and the probability of disruption being low" than from "being able to be reborn even if disrupted."

The honest conclusion from Baillie Gifford's lens: the error-correction culture is passable (facing bad news, willing to take impairments and shrink), but the self-reinvention/renewal genes are weak (repeated failures at opening a second curve). For a framework seeking "century-defining great growth stocks," this is a minus—it looks more like a "consolidator" enterprise than one "able to rebuild on the ruins."

Jun 10, 2026
Does management (especially the founders) have a long-term vision, with interests deeply tied to the company? Are they willing to sacrifice current profit for five to ten years out?5/10

Conclusion: the long-term vision is "partly present," but the "deep interest alignment" has clearly weakened in recent years—one factual correction to the report is needed here. The company has no incumbent founder holding a large stake; the Sands family voluntarily gave up super-voting control in 2022; the new CEO has just taken office with a small personal stake; and the "Berkshire long-term large-shareholder endorsement" cited in the report had, in fact, essentially ceased to hold before STZ's report date (2026-05-29). On this Baillie Gifford dimension, STZ's "management × company" interest alignment is "moderately weak."

First, correct one load-bearing fact. The report writes "Berkshire Hathaway also held about 6.8%" and argues from it that "the company does have relatively long-term-oriented large shareholders behind it." But per public SEC filings, Berkshire briefly increased its stake to 13.4 million shares (about 7.6%) at the end of 2025, then sharply cut it in the first quarter of 2026—the 13G/A filed on 2026-05-15 shows only 632,890 shares remaining, about 0.4%, a roughly 95% reduction from the prior level, and CNBC also reported this as Berkshire's new management "nearly liquidating" STZ in a portfolio overhaul. In other words, by the report's cutoff date, Berkshire was no longer a long-term backer of STZ—this reverses the "large-shareholder long-term orientation" argument and should mark it down, not up.

Family alignment: still the largest single shareholder, but no longer with super-voting control. The Sands family once held about 59.5% of the voting power through Class B (10 votes per share, with the family holding about 98% of the B shares), but in 2022 the family voluntarily agreed to eliminate Class B and convert to a single share structure, cutting voting power to below about 20% and receiving $1.5 billion in consideration. On the report's basis the family still holds about 12% of Class A and retains some director-nomination rights. This is both a positive and a neutral: the family has long-term reputation and continuity, but it has itself given up the institutional control tool for "sacrificing the present for five to ten years out"—it can no longer suppress short-termism the way a founder-controlled company can.

Professional-manager alignment is weak, plus handover-period uncertainty. The report notes that, per the latest verifiable proxy, the direct holdings of executives such as William Newlands, Garth Hankinson, and Nicholas Fink are all small, so personal economic alignment is not strong. Add the leadership transition—on 2026-02-12 the company announced that Nicholas Fink would take over as CEO effective 2026-04-13, with Newlands stepping down and leaving the board—and the new team has not yet completed a full operating cycle inside STZ, which itself adds execution uncertainty. On the Baillie Gifford supplementary question "willing to sacrifice current profit for five to ten years out": the company is indeed making long-cycle investments (Mexican Veracruz capacity, over $200 million in cost savings by 2028), and the direction is long-term; but this looks more like steady operation than a "founder-style" willingness to sacrifice the present for the distant future.

The honest conclusion from Baillie Gifford's lens: no strong incumbent founder, the family has ceded control, managers hold little, and the long-term-backing institution (Berkshire) is instead exiting—on Baillie Gifford's core preference for "deep interest alignment" between management and company, STZ can only be rated moderately weak. The report gives "is management trustworthy: uncertain" and "3/5," which is directionally right; but its Berkshire-holding argument needs to be corrected per the real-time filings above.

Jun 10, 2026
If it disappeared tomorrow, how much would customers miss it? Is its growth model sustainable and not reliant on harming society or evading regulation?5/10

Conclusion: the "would be missed" degree is moderate—Corona/Modelo have strong brand mindshare and occasion-based irreplaceability, but the beer category as a whole is fairly replaceable; the growth model is broadly compliant and sustainable, and the only things needing constant vigilance are "alcohol's inherent externalities on society + policy/tariff sensitivity." On this dual Baillie Gifford supplementary question (indispensability + social/regulatory sustainability), STZ is "relatively strong on indispensability, broadly passing on sustainability but with structural constraints."

First, "if it disappeared tomorrow, how much would customers miss it." In the specific setting of high-end imported beer, the degree of missing it is not low: Corona, Modelo Especial, Pacifico, and others are brands with strong cultural and occasion-based bonds, the company is a perennial No. 1 U.S. high-end beer supplier and keeps taking share in Circana-tracked channels, and FY2026 Beer operating income of $3.161 billion, about a 38% operating margin, itself reflects consumers' willingness to pay a premium for these brands. The report also corroborates that the demand base is "not built purely on promotions," but rests on brand preference and channel availability (Beer once achieved volume growth for 15 consecutive years).

But to be honest—it is more replaceable than the top-tier consumer franchises. The report's moat matrix rates "switching cost" as "weak": the cost for consumers to switch beer brands is low, relying mainly on "brand preference and occasion-based mindshare" for soft stickiness. If it disappeared, there would be regret, but Hispanic and mainstream consumers could find close substitutes among other Mexican/imported/craft brands; this is not "irreplaceable" like certain addictive or network-type products. Full-year FY2026 Beer depletions of -2.1% is another reminder: when the customer base's wallet tightens, they do buy less or trade down—precisely the real-world evidence of "limited indispensability."

Filling in the first implied premise—"not reliant on harming society or evading regulation." The growth model is broadly healthy: relying on brand, product-mix upgrades, compliant price increases, and channel cultivation, rather than predatory means; the company's exit from the cannabis bet and shrinking of the problematic wine business actually converge rather than expand its controversial exposure. But two structural constraints must be written honestly: (1) alcoholic beverages themselves carry public-health externalities, suppressed over the long run by rising health awareness, demographics, and regulation (taxes, advertising, drinking age), an industry headwind the report repeatedly stresses that will not disappear; (2) policy and tariff sensitivity—core beer profit depends heavily on the smooth cross-border link between Mexican production and the U.S. market, and the report notes that in FY2026 the company explicitly mentioned some businesses being affected by U.S. tariffs and retaliatory measures. This is not "harming society for growth," but it means the sustainability of its growth is constrained by external policy and not fully self-determined.

Filling in the second implied premise—"social/regulatory sustainability." On balance, STZ is not the type that "grows big by harming society or exploiting regulatory loopholes," and its sustainability passes; the real risk is not "being banned by regulators," but "demand being eroded over the long run by health/economic trends + cross-border costs being repriced by policy."

The honest conclusion from Baillie Gifford's lens: as a brand it would be moderately missed, with a real premium and occasion-based mindshare, and its indispensability is stronger than ordinary beer; but low switching cost + a replaceable category + policy sensitivity make its "indispensability" bounded. On this dimension STZ is moderately above average, but does not reach the tier in Baillie Gifford's mind of "the world would clearly be worse off if it disappeared."

Jun 10, 2026
How is this business's unit economics (gross margin, incremental returns)? Do they get better or worse as it scales? Where does the money it earns go?7/10

Conclusion: unit economics is this business's strongest side—beer's roughly 38% operating margin, a gross margin of about 52%, and strong free-cash-flow conversion; but the flywheel of "unit economics getting better as it scales" has essentially topped out, and the money it earns mainly flows back to shareholders (dividends + buybacks) and debt repayment, rather than high-return reinvestment. On this Baillie Gifford question, STZ has "strong current unit economics, but incremental returns no longer expanding."

First, the absolute level—excellent. In FY2026 the company's total gross profit was $4.712 billion (gross margin about 51.6%) and operating income $2.721 billion; the core engine, beer, is stronger still, with Beer net sales of $8.315 billion and operating income of $3.161 billion, an operating margin of about 38%. Such margins are first-tier among consumer goods, with good cash character—FY2026 operating cash flow of $2.669 billion and free cash flow of $1.794 billion. The report also notes that cumulative free cash flow over the five years (FY2022–FY2026) was about $8.64 billion, far above cumulative net income to shareholders of about $3.22 billion, proving that at the core operating level profit quality is solid, and accounting impairments are the source of the "surface earnings" distortion.

But "does it get better or worse as it scales"—the margin is flattening or even under pressure, not continuing to amplify. Three pieces of evidence: (1) FY2026 overall operating margin is dragged by demand and mix, and the company's FY2027 operating-margin guidance of only 32%–33% does not point to further margin expansion; (2) comparable EPS fell 14% year over year from FY2026's $11.82—scale has not brought incremental earnings; (3) this is not a "barely needs any more capital" asset-light business—the report stresses beer still needs ongoing capacity, packaging, logistics, and marketing investment, and FY2027 still requires about $800 million of capex (including Mexican Veracruz expansion). In other words, the return on incremental capital tends toward mediocrity in a mature market, and the scale-effect dividend has largely been harvested.

Chain extension—"where does the money it earns go." Capital allocation is centered on shareholder returns and deleveraging: in FY2026 the company returned more than $1.6 billion to shareholders, of which buybacks exceeded $900 million; in 2025 the board newly approved a $4 billion repurchase authorization expiring in 2028; debt fell from about $12.46 billion in FY2023 to about $10.57 billion in FY2026. The problem is buyback quality: in February 2026 the company bought back at an average of about $154.60, and after April at about $153.86, while the recent share price is about $140–144, showing the buybacks look more like a routine capital-return tool than shrewd counter-cyclical, well-timed allocation. The historical massive wine impairment shows even more directly that once "the money it earns" is put into non-core areas, the returns are not pretty.

The honest conclusion from Baillie Gifford's lens: the "quality" of unit economics is STZ's strongest dimension of all (high gross margin, high operating margin, strong FCF), far more solid than many not-yet-profitable growth stocks; but Baillie Gifford also asks "do incremental returns get better as it scales," and STZ's incremental returns have flattened, reinvestment opportunities are limited, and surplus cash mainly goes to shareholders rather than being compounded via reinvestment—this is a "cash cow" character, not a "compounding machine of high incremental returns."

Jun 10, 2026
For it to rise fivefold in ten years, which conditions must hold simultaneously? Are these conditions realistic? What expectations does today's share price imply?3/10

Conclusion: rising fivefold in ten years (≈17.5% annualized) is almost unrealistic for STZ—it requires several rather optimistic conditions to hold at once, and a few of the key ones run counter to the current trend. Today's share price does not imply a "high-growth" expectation; instead it implies a mature-cash-cow pricing of "low-single-digit growth + one-off impairment repair." On this core Baillie Gifford supplementary question, STZ's odds structure clearly tells you it is not an LTGG target.

First, unpack "which conditions must hold simultaneously for a fivefold in ten years." Starting from a recent share price of about $140–144 and a market cap in the roughly $24.0 billion–$24.7 billion range, a fivefold in ten years requires the market cap to reach around $120 billion. This requires: (1) beer demand reversing from the current full-year depletions of -2.1% contraction to sustained mid-to-high-single-digit volume growth; (2) pricing power stacking on top of volume growth without being bitten back by demand elasticity; (3) operating margin rising further from the FY2027 guidance of 32%–33%; (4) wine no longer being impaired after restructuring, even returning to growth; (5) the valuation multiple expanding sharply from the current roughly 12x comparable P/E. These five must hold at once—yet (1) directly contradicts current facts (volume is falling), and (5) is wishful for a mature beverage stock. The report's own key assumption is set only at "Beer recovering to at least low-single-digit growth over the next 2–3 years," and even the most optimistic internal assumption is an order of magnitude away from "fivefold." "Unrealistic" is the honest conclusion for these conditions.

Next, "what expectations does today's share price imply"—it implies low expectations, not high ones. Three bases corroborate each other: (a) on FY2026 comparable EPS of $11.82, the current price is about 12x—a "low-growth mature stock" multiple, far below any growth-stock pricing; (b) on FY2026 free cash flow of $1.794 billion and the current market cap, the equity FCF yield is about 7%+, and the report's owner-earnings yield is about 8.6%; (c) the dividend yield is about 2.77%–2.94%. A stock the market expects to grow fast would not be handed a 12x P/E and a 7%+ FCF yield. In other words, the market already prices STZ as a "relying-on-cash-returns, low-speed-growth" name—the opposite of Baillie Gifford's prey profile of "finding undervalued high growth": it is not a wrongly-punished growth stock, but a reasonably-priced cash cow.

A symmetry worth flagging: precisely because expectations are already depressed, STZ's downside protection is better than a typical growth stock's. The report's conservative intrinsic-value range of $145–160 and fair range of $180–220 mean the current price has only a very shallow discount to conservative value and a moderate discount to fair value—this is "a value stock's odds," where the win comes from valuation repair and stable cash returns, not a tenfold-scale growth payoff. The report's final rating "Watch" and its explicit "margin of safety insufficient" are consistent with this.

The honest conclusion from Baillie Gifford's lens: on the checklist of conditions for a fivefold in ten years, the decisive few (volume returning to high growth, margins rising again, the multiple expanding sharply) are all of low likelihood and run counter to current data. Today's share price implies a mature expectation of "low-single-digit growth + impairment repair," not a high-growth expectation—which precisely shows it is not the "great growth stock the market has not yet realized" that Baillie Gifford seeks, but a broadly reasonably-priced high-quality cash cow. On this dimension, record it honestly as "weak."

Jun 10, 2026
Why hasn't the market realized all this yet? Is it not understanding, not respecting, or not seeing far enough? What would become the "narrative inflection point"?3/10

Conclusion: this question applies in "reverse"—the market has in fact "understood" STZ and has not systematically misread it. The current pricing of about 12x comparable P/E accurately reflects the reality of "a high-quality beer franchise + volume under pressure + a blemished non-core allocation record." What the market truly "cannot see clearly" is only a rather narrow perception gap: accounting impairments distort surface earnings and mask the fact that the core beer is still spitting out strong cash. Where Baillie Gifford's question asks "why hasn't the market realized," the most honest answer for STZ is: the market has largely realized it, and there is no huge expectations gap.

First, why it is "not badly misread." Baillie Gifford's prey is a great growth stock that "the market does not understand / does not respect / does not see far enough"; yet STZ's pricing shows precisely that the market sees it quite clearly: (1) it assigns about 12x comparable P/E (on FY2026 comparable EPS of $11.82) and about a 7%+ FCF yield—exactly the multiple a "low-growth mature consumer stock" should have, not the price of a wrongly-punished growth stock; (2) it does not grant the beer moat an excessive premium, because the volume pressure of full-year Beer depletions -2.1% and shipments -3.8% is public and already priced in; (3) even the benchmark of long-term value investors is voting with its feet—Berkshire cut its STZ position by about 95% to 0.4% in Q1 2026, and CNBC reported it as nearly liquidating. When the most famous value buyer is exiting, it shows the market is not "failing to realize the value," but pricing its growth and certainty cautiously.

So what is the only, rather narrow perception gap that does exist—"not seeing through the accounting noise." This is where STZ may truly be undervalued, and it is the report's core bull logic: FY2025's massive wine impairment pushed the TTM GAAP P/E up to about 23.9x, making cursory investors think it "expensive"; but if you strip out the one-off impairment and look at comparable EPS and cash flow, the core beer franchise is still spitting out cash at about a 38% operating margin (FY2026 Beer operating income of $3.161 billion, all-in free cash flow of $1.794 billion). The report puts it precisely: "what is truly attractive is not the GAAP P/E, but that beneath the distorted accounting earnings, the core beer is still spitting out very strong cash." This is a small discount of "not respecting / not seeing through the surface," not a huge growth-expectations gap of "not seeing far enough."

Filling in the implied premise in the chain—"what would become the narrative inflection point." To retell STZ from a "low-growth beer stock" into a higher-valuation story requires a clear inflection signal, and none has appeared today: (1) Beer depletions/shipments turning positive again and stabilizing for several quarters—this is the most direct inflection, and the report also lists it as the primary signal to trigger a reassessment; (2) FY2027 operating cash flow truly landing within the $2.4–2.5 billion guidance range, with GAAP profit no longer polluted by new impairments, so that "the accounting noise fades and true earnings show through"; (3) the wine divestiture being fully completed with no more repeated write-downs; (4) the new CEO Nicholas Fink completing a full cycle and proving he will not repeat non-core capital misallocation. The reverse inflection (narrative turning worse) is equally clear: depletions continuing to deteriorate, Beer operating margin breaking below 35%, net leverage rising again, or another large impairment.

The honest conclusion from Baillie Gifford's lens: this "why hasn't the market realized" barely applies to STZ—the market understands it is a high-quality cash cow rather than a great growth stock, the pricing is broadly fair, and benchmark value investors are even leaving. What can be captured is only the narrow perception gap that "accounting impairments mask core cash," and the odds are of the value-repair type, not the growth-rerating type. The narrative inflection hinges on whether beer volume can turn positive again; until then, the more reasonable stance is the report's "high-priority watch," not treating it as a growth stock awaiting the market's epiphany.

Jun 10, 2026

Ask about this report

Members can ask about this report; once answered it appears under "Reader Q&A" on this page. You can also highlight a passage in the text to ask about it directly.